Imetit dihydrobromide from Tocris Bioscience, a Bio-Techne Brand | Biocompare.com

Supplier Images

Imetit dihydrobromide

Standard H3 and H4 agonist (H3 > H4)
Imetit dihydrobromide

Cat.No. 0729 - Imetit dihydrobromide C6H10N4S.2HBr CAS No. 32385-58-3

Be the first to write a review!

Citations:

Supplier Page from
Tocris Bioscience, a Bio-Techne Brand for
Imetit dihydrobromide

Description

Standard H3 and H4 agonist (H3 > H4)

Product Specs
ItemImetit dihydrobromide
CompanyTocris Bioscience, a Bio-Techne Brand
Price $157.00Supplier Page View Company Product Page
Catalog Number0729/10
Purity98%
Molecular Weight332.06
Molecule Name5-[2-(Imidazol-4-yl)ethyl]isothiourea dihydrobromide
FormulaC6H10N4S.2HBr
StorageStore at RT
Quantity10 mg (also 50 mg)

Specifications/Features

Sizes Available: 10 mg (also 50 mg)

Add to Compare List

Tocris Bioscience, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956
Fax: 1 (612) 656-4400

Company Profile

Website: http://www.tocris.com

(1) High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell deathProceedings of the National Academy of Sciences of the United States of AmericaApril 3, 2012Fox JT, Sakamuru S, Huang R, Teneva N, Simmons SO, Xia M, Tice RR, Austin CP, Myung K.

(2) Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heartThe Journal of pharmacology and experimental therapeuticsJanuary 1, 2012Hashikawa-Hobara N, Chan NY, Levi R.

(3) Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitusProceedings of the National Academy of Sciences of the United States of AmericaSeptember 12, 2006Yoshimoto R, Miyamoto Y, Shimamura K, Ishihara A, Takahashi K, Kotani H, Chen AS, Chen HY, Macneil DJ, Kanatani A, et al.

(4) Histamine-induced inhibition of leukotriene biosynthesis in human neutrophils: involvement of the H2 receptor and cAMPBritish journal of pharmacologyFebruary 1, 2004Flamand N, Plante H, Picard S, Laviolette M, Borgeat P.

Be the First to Write a Review!